S Harris Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
1,640
-66
-4% -$9.89K 0.2% 93
2026
Q1
$261K Buy
+1,706
New +$262K 0.24% 79

Other funds holding NVS

S Harris Financial Group's NVS Position: Q2 2026 in Review

S Harris Financial Group reduced its Novartis (NVS) stake by 3.9% in Q2 2026, selling an estimated $9.89K and leaving 1,640 shares worth $257K. The position accounts for 0.2% of the portfolio, ranked #93.

S Harris Financial Group first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $261K in Q1 2026. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • S Harris Financial Group held 1,640 shares of Novartis worth $257K as of Q2 2026.
  • S Harris Financial Group sold 66 Novartis shares in Q2 2026, an estimated $9.89K.
  • Novartis made up 0.2% of S Harris Financial Group's portfolio in Q2 2026, its #93 holding.
  • S Harris Financial Group first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
  • S Harris Financial Group's Novartis position peaked at $261K in Q1 2026.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on S Harris Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.